Nanomaterials for Cardiac Tissue Engineering.
Devang R AminEric SinkSuguna P NarayanMostafa Abdel-HafizLuisa MestroniDaewon ParkPublished in: Molecules (Basel, Switzerland) (2020)
End stage heart failure is a major cause of death in the US. At present, organ transplant and left-ventricular assist devices remain the only viable treatments for these patients. Cardiac tissue engineering presents the possibility of a new option. Nanomaterials such as gold nanorods (AuNRs) and carbon nanotubes (CNTs) present unique properties that are beneficial for cardiac tissue engineering approaches. In particular, these nanomaterials can modulate electrical conductivity, hardness, and roughness of bulk materials to improve tissue functionality. Moreover, they can deliver bioactive cargo to affect cell phenotypes. This review covers recent advances in the use of nanomaterials for cardiac tissue engineering.
Keyphrases
- tissue engineering
- left ventricular
- heart failure
- carbon nanotubes
- cardiac resynchronization therapy
- acute myocardial infarction
- end stage renal disease
- ejection fraction
- mitral valve
- prognostic factors
- atrial fibrillation
- bone marrow
- percutaneous coronary intervention
- mesenchymal stem cells
- acute coronary syndrome
- transcatheter aortic valve replacement
- reduced graphene oxide